Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis

Aspergillosis in Solid Organ Transplantation

(2013) N. M. Singh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Preemptive treatment with voriconazole in lung transplant recipients

(2013) C.F. Neoh et al.   Transplant Infectious Disease

Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients

(2012) M-L. Luong et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity

(2012) Dimitra Mitsani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients

(2012) Nete Tofte et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation

(2012) Sophia Koo et al.   TRANSPLANTATION

Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey

(2011) C. F. Neoh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients

(2011) Shahid Husain et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Invasive Fungal Infections in Lung Transplant Recipients Not Receiving Routine Systemic Antifungal Prophylaxis: 12-Year Experience at a University Lung Transplant Center

(2011) Marlena F Pinney et al.   PHARMACOTHERAPY

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

(2010) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation

(2010) Víctor Monforte et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients

(2010) D. Neofytos et al.   Transplant Infectious Disease

Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients

(2010) Shahid Husain et al.   TRANSPLANTATION

Control of Early Aspergillus Mortality After Lung Transplantation: Outcome and Risk Factors

(2010) M. Eriksson et al.   TRANSPLANTATION PROCEEDINGS

An Unwelcome Guest: Aspergillus Colonization in Lung Transplantation and Its Association with Bronchiolitis Obliterans Syndrome

(2009) S. Garantziotis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome

(2009) S. S. Weigt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness

(2009) J. Cadena et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data

(2009) Byron C Wallace et al.   BMC Medical Research Methodology

Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety

(2009) Víctor Monforte et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation

(2008) J.M. Borro et al.   TRANSPLANTATION PROCEEDINGS